Side-by-side comparison of AI visibility scores, market position, and capabilities
Amazon's pharmacy combining PillPack multi-medication pre-sorting with Prime prescription delivery; disrupting CVS and Walgreens with price transparency and same-day delivery in growing cities.
PillPack (now Amazon Pharmacy) is Amazon's full-service online pharmacy providing prescription delivery, medication management, and pharmacy services to US customers — originally founded as PillPack in 2013 by TJ Parker and Elliott Cohen to solve medication adherence for patients on multiple prescriptions, then acquired by Amazon in 2018 for $1 billion. Amazon has since rebranded the full-service pharmacy to Amazon Pharmacy while maintaining the PillPack brand for the multi-medication pre-sorting service for customers taking 5+ daily medications.\n\nPillPack's distinctive original service pre-sorts medications by dose and time (individual packets labeled "Monday 8AM: Take these 3 pills"), eliminating the confusion of managing multiple prescription bottles for patients with complex medication regimens. This packaging format particularly serves elderly patients and chronic disease patients taking 5-15 medications daily. Amazon Pharmacy (the broader service) provides standard prescription delivery with Prime shipping, price transparency through Amazon's prescription discount program, and pharmacist consultations.\n\nIn 2025, Amazon Pharmacy operates as a significant disruptor in the $350 billion US prescription market, competing with CVS Health (the largest pharmacy chain), Walgreens, Express Scripts (mail-order PBM pharmacy), and new pharmacy entrants like Ro, Alto Pharmacy, and Capsule. Amazon's advantages are its logistics infrastructure (Prime 2-day/same-day delivery), price comparison transparency, and consumer trust for e-commerce transactions. The 2025 strategy focuses on expanding same-day prescription delivery in more cities, growing specialty pharmacy capabilities for high-cost biologic medications, and integrating pharmacy with Amazon's broader health ecosystem (One Medical primary care, Amazon HealthLake health records).
Armonk NY hybrid cloud and enterprise AI (NYSE: IBM) at $62.8B revenue; $6B+ generative AI bookings, record $12.7B free cash flow 2024, DataStax acquisition for watsonx vector database competing with Microsoft Azure for enterprise AI.
International Business Machines Corporation (IBM) is an Armonk, New York-based global technology and consulting company — publicly traded on the New York Stock Exchange (NYSE: IBM) as an S&P 500 component — providing hybrid cloud infrastructure, artificial intelligence software, and enterprise IT consulting through approximately 270,300 employees in 170 countries with $62.8 billion in annual revenue. Founded on June 16, 1911, as Computing-Tabulating-Recording Company through a merger orchestrated by financier Charles Ranlett Flint, renamed IBM in 1924 under Thomas Watson Sr., IBM has undergone multiple strategic transformations over its 110+ year history: building the System/360 mainframe platform (1964), launching the IBM PC (1981), selling the PC division to Lenovo (2005, $1.75B), and completing the $34 billion Red Hat acquisition (2019) that repositioned IBM as a hybrid cloud platform company. CEO Arvind Krishna (appointed April 2020) has focused IBM's strategy on three areas: hybrid cloud (powered by Red Hat OpenShift, the enterprise Kubernetes platform), AI (the watsonx platform for enterprise AI model development and deployment), and enterprise consulting. Under Krishna, IBM recorded $12.7 billion in free cash flow in 2024 (a company record), surpassed $6 billion in generative AI bookings since June 2023, and saw the stock price double — trading at all-time highs through 2024-2025. IBM announced the DataStax acquisition in 2025 to deepen watsonx's data layer with AstraDB (vector database for AI applications), DataStax Enterprise (Apache Cassandra), and Langflow (low-code AI agent development).
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.